HomePOLYMED › Filing
🔔 Get instant alerts when POLYMED files quarterly results on BSE Start free trial →

ENCLOSED

Filed: 07 Aug 2026, 14:56 IST Exchange: BSE Category: Financial Results — Audited Results
Q1FY27 results (unaudited): Standalone: Revenue 4.3bn +12% y-y (3.8bn) PAT 0.88bn +0% y-y (0.88bn) Consolidated: Revenue 5.3bn +30% y-y (4.0bn) PAT 0.86bn -7% y-y (0.93bn) FY26 results (audited): Standalone: Revenue 16.6bn +10% y-y (15.1bn) EBITDA 12.0bn +9% y-y (11.0bn) EBITDA margin 72.2% (72.7%) -50 bps y-y PAT 8.1bn +9% y-y (7.5bn) Consolidated: Revenue 18.8bn +11% y-y (16.9bn) EBITDA 12.0bn +8% y-y (11.1bn) EBITDA margin 64.0% (65.5%) -150 bps y-y PAT 9.0bn +10% y-y (8.2bn) Dividend: Not stated Commentary: Board approved grant of 1,476 stock options and allotment of 1,975 equity shares under ESOP scheme; re-appointed cost auditors; resignation of Deputy Company Secretary effective 10 August 2026.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 POLYMED — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add POLYMED to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Poly Medicure Limited

Important. The summary above is generated automatically from Poly Medicure Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.